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The aim was to evaluate the presence of Staphylococcus spp., Enterobacteriaceae and Pseudo-
monadaceae in the oral cavities of HIV-positive patients. Forty-five individuals diagnosed as
HIV-positive by ELISA and Western-blot, and under anti-retroviral therapy for at least 1 year,
were included in the study. The control group constituted 45 systemically healthy individu-
als matched to the HIV patients to gender, age and oral conditions. Oral rinses were collected
and isolates were identified by API system. Counts of microorganisms from HIV and control
groups were compared statistically by a Mann–Whitney test (a = 5%). The percentages of
individuals positive for staphylococci were similar between the groups ( p = 0.764), whereas
for Gram-negative rods, a higher percentage was observed amongst HIV-positive ( p = 0.001).
There was no difference in Staphylococcus counts between HIV and control groups
( p = 0.1008). Counts were lower in the oral cavities of patients with low viral load
( p = 0.021), and no difference was observed in relation to CD4 counts ( p = 0.929). Staphylo-
coccus aureus was the most frequently isolated species in HIV group, and Staphylococcus
epidermidis was the prevalent species in the control group. Significantly higher numbers of
enteric bacteria and pseudomonas were detected in the oral cavities of the HIV group than in
the control ( p = 0.0001). Enterobacter cloacae was the most frequently isolated species in both
groups. Counts of enteric bacteria and pseudomonas were significantly lower in patients
with low CD4 counts ( p = 0.011); however, there was no difference relating to viral load. It
may be concluded that HIV group showed greater species diversity and a higher prevalence
of Enterobacteriaceae/Pseudomonadaceae.
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The oral cavity is inhabited by more than seven hundred
microbial species. Many intrinsic and extrinsic factors have
effects on the composition, metabolic activity, and pathoge-
nicity of the oral microflora.1,2 The oral microflora are
remarkably stable in healthy subjects, but significant changes
may occur in subjects facing serious systemic disease and its
treatment. An imbalance in the commensal flora may occur in
immunosuppressed individuals or those under antibiotic
therapy, favouring the growth of some microorganisms and
causing opportunistic infections.3–5
Considerable controversy remains as to whether
Staphylococcus spp. play a role in the ecology of the normal
oral flora. The role of S. aureus in several diseases of the oral
mucosa merits further investigation. Smith et al.6 stated that
staphylococci are not infrequent colonizers of the oral cavity,
and that this site may serve as a potential reservoir for
transmission to other body sites. Zuanazzi et al.7 reported that
the most prevalent bacteria in the saliva of hospitalized
individuals were Staphylococcus spp. (85.7%), Pseudomonas spp.
(83.8%), and Acinetobacter spp. (53.3%). The results of another
study suggested a possible peroral route for staphylococci, as
the provision of microorganisms from the nasal cavity was
shown.8
Staphylococcus species are amongst the most frequent
causes of bacteremia in mechanically ventilated patients.9
Further work in this area may lead to benefits such as
improved decolonization regimens for eradication of MRSA
and acknowledgement of the mouth as a source of bacter-
emia-causing staphylococci.10
Microorganisms of the Enterobacteriaceae and Pseudomona-
daceae families have been thoroughly investigated by the
medical field and are known for their pathogenicity in
humans; however, these bacteria have not been considered
pathogenic in the oral cavity. Despite this, the presence of
these bacteria in the oral cavity can serve as a reservoir,
and can severely compromise the lives of immunocompro-
mised individuals.11–14 Some studies have reported an
association between Enterobacteriaceae and oral ulcerations
in HIV-positive patients, but this association may not
necessarily be causal, as enterobacteria may be secondary
invaders.15,16
Local and systemic factors appear to be correlated with
increased oral prevalence of Enterobacteriaceae and/or Pseudo-
monas. However, the percentage of oral isolates containing
these species differs amongst reports from different groups
and remains controversial.3,14,17,18
Despite the importance of this subject, few studies of
Enterobacteriaceae and/or Pseudomonas in the oral cavities of
HIV-positive patients have been performed in Brazil. Most
of the published studies have focused on Candida spp.
Because oral reservoirs of potential pathogens such as
enterobacteria and staphylococci may also cause local or
systemic infections and compromise the lives of immuno-
suppressed individuals, the aim of this study was to evaluate
the presence of Staphylococcus spp., Enterobacteriaceae
and Pseudomonadaceae in the oral cavities of HIV-positive
patients.2. Materials and methods
This study was approved by the Local Ethics Committee
(protocol number 012-PH/CEP) and was undertaken with the
informed written consent of each subject.
Forty-five individuals (23 female and 22 male), aged 22–
66 years, HIV-positive as diagnosed by ELISA and confirmed by
Western blot, undergoing treatment at the Day Hospital of
Taubate´ Medical School or Medical Specialties Center (Sa˜o
Paulo State; ARE), and having undergone anti-retroviral
therapy for at least 1 year were included in the study. Of
the total, 43% of the patients were undergoing highly active
antiretroviral therapy (HAART), and the remaining patients
were treated only with a protease inhibitor. For the control
group, 45 healthy individuals were selected amongst the
patients under treatment at Sa˜o Jose´ dos Campos Dental
School. They were aged 23–66 years, with similar age
(2 years), gender and oral conditions (use of dentures or
orthodontic devices and smoking; salivary flow was not
evaluated) to the HIV-positive individuals.
The most recent data for the values of the CD4 cell count,
viral load, antiretroviral treatment and antibiotic use were
obtained from the medical records of the HIV group.
Antimicrobial/antifungal therapy during the 3 months pre-
ceding the sampling, diabetes mellitus, use of antidepressant
drugs, pregnancy and use of orthodontic appliances were
considered exclusion criteria.
Samples from each individual were collected by oral rinses
with phosphate-buffered saline (PBS; 0.1 M, pH 7.2) for
10 min.19 The samples were centrifuged for 10 min at
8000  g and the supernatant was discarded. The pellets were
resuspended in 2.5 ml of PBS. Dilutions of 101 and 102 in PBS
were made, and an aliquot (0.1 ml) of each dilution was plated
on mannitol agar (Difco, USA) and MacConkey agar (Difco,
USA) in duplicate. Plates were incubated at 37 8C for 48 h. After
this period, colonies were counted and the number of colony-
forming units per millilitre (cfu/ml) was obtained. Colonies
with different morphologies were subjected to microscopic
confirmation and were isolated and stored in gelose agar at
room temperature.
Coagulase-positive Staphylococcus isolates were identified
according to the phenotypic tests proposed by Koneman
et al.20Coagulase-negative isolates were identified using the API
Staph system (Biomerieux, France). Isolates of Gram-negative
rods were identified using the API 20E system (Biomerieux,
France), according to the manufacturer’s instructions.
2.1. Analysis of data
The proportions of individuals positive for the studied
microorganisms in the control and experimental groups were
compared by a Z-test. Counts of the microorganisms obtained
for HIV-positive and control groups were compared by a
Mann–Whitney test. The Kruskal–Wallis ANOVA was used to
compare the counts of microorganisms according to CD4 cell
count and viral load in HIV-positive patients. Values of p  0.05
were considered statistically significant.
For comparison purposes, patients were classified into 3
subgroups according to counts (cells/mm3) of CD4 lympho-
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therapy guidelines for adults and adolescents infected with
HIV.21,22 Patients were also divided into subgroups based on
viral load (<400, 400–20,000 and >20,000 copies/ml of serum).
3. Results
Similar numbers of HIV-positive patients were positive for
staphylococci (84.4%) compared to the control group (86.6%)
( p = 0.764). There was no statistically significant difference in
the staphylococcus counts obtained from the oral cavities of
control subjects and HIV-positive patients ( p = 0.9839)
(Table 1).
S. aureus was the most frequently isolated species in the
HIV-positive group (30.2%). In contrast, Staphylococcus epider-
midis (31.4%) was the most frequently isolated species
amongst the controls (Table 2).
No significant differences in staphylococcus counts were
observed amongst the subgroups for CD4T cells; however,
counts were significantly lower in the subgroup with a viral
load of less than 400 copies/mm3 (Table 3).
The HIV-positive group showed a higher percentage of
individuals positive for Enterobacteriaceae and Pseudomonada-
ceae (77.7%) than the control (44.4%) ( p = 0.001). Also, the
counts of these microorganisms were significantly higher
amongst HIV-positive patients than in the control group
( p = 0.0001) (Table 1).Table 1 – Oral levels of the microorganisms (colony-
forming units per millilitre; cfu/ml) obtained for the
control and HIV groups.
Median Interquantile
range
p
HIV Control HIV Control
S 1140 1300 3110 2180 0.9839
E/P 620 0 1850 90 0.0001
S: Staphylococcus spp. E/P: Enterobacteriaceae/Pseudomonadaceae, and
p = p-value.
Table 2 – Staphylococci isolates identified in HIV and
control groups.
Species HIV Control
n % n %
Staphylococcus aureus 73 92.4 48 54
Staphylococcus epidermidis 69 47 68 61.8
Staphylococcus haemolyticus 14 9.5 4 3.6
Staphylococcus saprophyticus 13 8.8 2 1.8
Staphylococcus warneri 12 8.1 3 2.7
Staphylococcus capitis 10 6.8 7 6.4
Staphylococcus hominis 9 6.1 5 4.5
Staphylococcus xylosus 7 4.7 4 3.6
Staphylococcus schleiferi 6 7.6 40 45.9
Staphylococcus chromogenes 6 4 0 0
Staphylococcus simulans 5 3.4 0 0
Staphylococcus sciuri 2 1.3 7 6.4
Staphylococcus lugdunensis 0 0 10 9Enterobacter cloacae was the most frequently isolated
species in both groups (18.8% in the HIV-positive group and
16.32% in the control group). Amongst Pseudomonadaceae
species, Chryseomonas luteola was the most common in both
studied groups (7.3% in the HIV-positive group and 6.1% in the
control group). Other species identified are shown in Table 4.
Counts of Enterobacteriaceae and Pseudomonadaceae were
significantly lower in the subgroup with <200 CD4 cells/mm3.
With respect to viral load, significantly lower counts of
staphylococci in the subgroup with <400 copies/mm3 were
observed (Table 3).
4. Discussion
One of the most challenging problems involving staphylococci
has been their increasing resistance to methicillin, vancomy-
cin and other antibiotics.23–25 Oral reservoirs of these micro-
organisms may be potential sources for infection in
immunosuppressed patients.26
In this study, staphylococci were isolated from 86.6% of the
control group and 84.4% of HIV-positive patients. Previous
studies reported a variable presence of staphylococcus in
systemically diseased patients. These values varied from 28%
amongst patients with malignant neoplasias3 to 96% in
patients with rheumatoid arthritis.27 High percentages of
patients positive for staphylococci in the oral cavity have been
reported in the literature, with values from 94%27 to 95.6%28
amongst adults. Jackson et al.29 also observed a higher
frequency of isolation in the oral cavities of healthy children
(92%).
The results obtained in this study confirm the conclusion of
Smith et al.10 that staphylococcus species can often be isolated
from the oral cavities of healthy or diseased children and
adults. Although staphylococci have been considered part of
the normal oral microbiota,27,29 their presence in the oral
cavity may be associated with local and systemic infections,
especially in immunosuppressed patients.10
With respect to the species identified in this study, S.
epidermidis and S. aureus were the most prevalent coagulase-
negative and coagulase-positive species, respectively, in both
groups. The isolation of these species in the oral cavity and
periodontal sites has been reported in the literature.27–31 The
HIV-positive group showed a greater diversity of coagulase-
negative species; the presence of S. warneri, S. capitis, S.
haemolyticus, S. xylosus, S. saprophyticus and S. hominis have
been reported in previous studies.26,27,29–32 In our results, S.
sciuri, S. simulans and S. chromogenes were identified. These
species were not found in previous studies of oral samples.
Some of these species, although isolated infrequently, may
cause infections in humans, such as urinary tract infections,
bacteremia, endocarditis, osteomyelitis, cellulitis and cerebral
empyema.33,34
Counts of staphylococci were lower in the oral cavities of
patients with low viral load (<400 copies/ml), but no difference
was observed in relation to CD4 cells. No previous studies were
found with which to compare these data.
Enterobacteria and pseudomonas were identified in the
oral cavities of 77.7% of the HIV-positive group. The control
group showed a lower isolation frequency (44.4%) in the oral
Table 3 – Descriptive analysis of data for the counts of microorganisms (cfu/ml) of the oral cavity according to the
subgroups related to CD4 cells (cells/mm3) and viral load (copies/ml).
CD4 T cells Median Interquartile range KW p
<200 200–500 >500 <200 200–500 >500
S 1030.0 620.00 640.00 2750 1720 4780 0.5523 0.7587
E/P 10,000 1680.0 60,000 4780 3090 1440 4.1778 0.1238
Viral load Median Interquartile range KW p
<400 400–20,000 >20,000 <400 400–20,000 >20,000
S 420.00 1420.0 690.00 1575 5775 3130 1.7137 0.4245
E/P 90,000 930.00 90,000 1405.0 2072.5 2310.0 0.7594 0.6841
S: Staphylococcus spp., E/P: Enterobacteriaceae/Pseudomonadaceae, KW: Kruskal–Wallis statistics test, and p: p-value.
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seems to be associated with systemic and local factors.
However, data in the literature are still controversial. Jobbins
et al.3 reported isolation of coliforms from 49% of patients with
malignancy. A low prevalence of these microorganisms in the
elderly and mentally disabled patients was reported.17,18
Senpuku et al.14 isolated Enterobacteriaceae from 16% of elderly
patients and from 6% of controls. A higher prevalence of
enterobacteria in the oral cavity was observed by Santos and
Jorge11 in healthy Brazilian individuals (51%). Ha¨gg et al.35
reported a significant increase in the prevalence of enter-
obacteria after insertion of fixed orthodontic appliances. Zhu
et al.,36 studying stroke patients at three different stages (acute
phase, upon discharge from the hospital and 6 months later),
observed that the oral carriage rate of coliforms wasTable 4 – Enterobacteria and pseudomonas isolates in HIV an
Species HIV 
n 
Enterobacter cloacae 27 
Klebsiella oxytoca 13 
Klebsiella pneumoniae 7 
Enterobacter sakazakii 8 
Escherichia coli 9 
Serratia marcescens 8 
Pantoea spp. 3 
Citrobacter freundii 6 
Serratia liquefaciens 2 
Klebsiella ornithinolytica 2 
Enterobacter asburiae 4 
Enterobacter aerogenes 2 
Serratia odorı´fera 3 
Kluyvera spp. 3 
Serratia ficaria 2 
Salmonella spp. 2 
Klebsiella terrigena 1 
Citrobacter koseri 1 
Enterobacter amnigenus 1 
Shigella spp. 0 
Serratia fonticola 1 
Enterobacter intermedius 1 
Chryseomonas luteola 10 
Pseudomonas aeruginosa 2 
Pseudomonas fluorescens 2 
Burkholderia cepacia 1 significantly lower at 6 months after hospital discharge, but
found no significant relationship between the presence of
coliforms and other variables studied (age, gender, plaque
index, bleeding index, DMFT, denture wearing, dysphagia,
smoking, diabetes and tooth brushing difficulty).
Other studies with HIV-positive patients in different
countries found a low prevalence of enterobacteria and/or
pseudomonas in the oral cavity. Schmidt-Westhausen et al.37
obtained an enterobacteria prevalence of 22%. Tsang and
Samaranayake15 reported the isolation of Enterobacteriaceae
(26.3%) and P. aeruginosa (15.1%). The only Brazilian study
regarding these microorganisms in the oral cavities of HIV-
positive patients was conducted by Figueireˆdo et al.,16 who
found Enterobaceriaceae in 96.4% of isolates and P. aeruginosa,
the only Pseudomonas identified, in 3.6% of isolates. Accordingd control groups.
Control
% n %
22.3 10 18.1
10.7 5 9
5.7 9 16.4
6.6 4 7.2
7.4 1 1.8
6.6 0 0
2.4 4 7.2
5 0 0
1.6 4 7.2
1.6 4 7.2
3.3 1 1.8
1.6 2 3.6
2.4 0 0
2.4 0 0
1.6 1 1.8
1.6 0 0
0.8 1 1.8
0.8 1 1.8
0.8 1 1.8
0 1 1.8
0.8 0 0
0.8 0 0
8.2 5 9
1.6 1 1.8
1.6 0 0
0.8 0 0
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in the prevalence of these microorganisms in the oral cavities
of individuals from developed and developing countries,
hypothesizing that the incidence of these microorganisms
in the oral cavity may be related to high numbers of coliforms
in drinking water and foods.
In the present study, E. cloacae and C. luteola were the most
prevalent species amongst isolates of Enterobacteriaceae and
Pseudomonaceae from both groups. E. cloacae has been fre-
quently identified amongst clinical oral isolates.11,12,26 How-
ever, C. luteola is rarely isolated from the oral cavity, and
infections caused by this microorganism include sepsis,
meningitis, endocarditis, osteomyelitis and peritonitis.20,38
The HIV group showed the greatest diversity of Enterobac-
teriaceae and Pseudomonas species, many of which can cause
opportunistic infections, such as Escherichia coli infections,
gastro-intestinal infections,39 endocarditis,40 urinary infec-
tions41 and Klebsiella pneumonia infections that are often
involved with aspiration pneumonia.42
With respect to CD4 cell count, lower counts of enter-
obacteria and pseudomonas were observed amongst patients
in the subgroup with <200 CD4 cells/mm3. This unexpected
result warrants further study. The viral load values were
distributed equally amongst the subgroups evaluated. Con-
sidering that the studies reporting the prevalence of enter-
obacteria and Pseudomonas in the oral cavities of HIV-positive
patients did not correlate their findings with clinical
variables, it was not possible to compare our results to the
literature. However, increased oral carriage of Gram-negative
bacilli in the HIV group compared to the control group
confirms that carriage rates tend to increase in medically
compromised individuals, and the presence of such bacteria
in the oral cavity as a putative reservoir of infection should be
considered.43
Regarding treatment, it was not possible to have a fixed
therapy protocol for all patients because the treatment
strategy would change according to the CD4 lymphocyte level
and viral load as well as other relevant clinical variables, such
as the occurrence of opportunistic diseases and adverse
reactions to medication. HAART is correlated with lower
occurrence of oral diseases. It promotes inhibition of viral
replication as well as redistribution and restoration of
immunity, resulting in an increase in CD4 cell counts. Within
the limits of this study, we could not assess the effect of
HAART on the oral microflora. The few studies on this subject
report that protease inhibitors may have anti-Candida activity
by inhibiting the protease of this microorganism.1,44
5. Conclusion
Based on the results obtained, it may be concluded that the
HIV-positive group showed a higher prevalence of Enterobac-
teriaceae and Pseudomonadaceae. No difference in staphylococ-
cus counts was found between the studied groups.
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